Demonstrates its commitment to providing quality, cost-saving treatment options to clinicians and the patients they serve.

Averaging up to 20% of weight loss, adults taking Zepbound had 25 fewer breathing interruptions each hour as they slept.

Integration of Ori's IRO Platform with Cue and Lovo processing systems aims to enhance efficiency in CGT manufacturing.

Novo Nordisk will soon acquire from Novo Holdings Catalent’s three fill-finish sites located in Italy, the U.S., and Belgium.

Will support the execution of a robust pipeline of customer projects for innovators developing groundbreaking in vivo and ex ...

Becomes the first subcutaneously administered PD-1 inhibitor.

Symbiosis Pharmaceutical Services, a Contract Manufacturing Organization (CMO) specializing in sterile GMP manufacturing of ...

The acquisition is expected to be completed in the coming days.

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines for the ...

Jubilant HollisterStier (JHS) has established itself as a leading player in the contract development and manufacturing ...

Will support clinical development of Nirsum’s lead development candidate, NRS-033.

Evidence of efficacy and safety data support the potential for vatiquinone to fill the significant unmet need for patients ...